Literature DB >> 20378642

The longevity of arteriovenous graft for hemodialysis patients--externally supported or nonsupported.

Yen-Ni Hung1, Po-Jen Ko, Yee-Yung Ng, Shiao-Chi Wu.   

Abstract

BACKGROUND AND OBJECTIVES: Because thrombosis and stenosis are the most frequent causes of arteriovenous graft (AVG) failure, several externally supported grafts were designed to enhance incompressibility and kinking resistance to improve the patency. However, consensus on advantage of these modifications having still not been reached might relate to the previous limited patient numbers and small studies. This study analyzed the longevity of externally supported and nonsupported AVG on the basis of the nationwide database to understand whether the externally supported design could improve the duration of patency of AVG. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Adult incident patients (n = 4402) were retrospectively enrolled who had began hemodialysis between January 1, 2002 and December 31, 2005. All incident patients with AVG, before or after beginning regular hemodialysis, between January 1, 2000 and December 31, 2006 were identified. The Cox proportional hazard model was used to compare the longevity of externally supported and nonsupported AVG by controlling other covariates.
RESULTS: There were 990 patients with externally supported AVG and 3412 patients with nonsupported AVG. The patency rates of externally supported AVG were 49.4%, 31.6%, and 20.2% at 1, 2 and 3 years, respectively; those of nonsupported AVG were 31.9%, 17.4%, and 10.8%. The survival of nonsupported AVG was significantly inferior to that of externally supported AVG.
CONCLUSIONS: Externally supported AVG are superior to nonsupported AVG for long-term patency. The incompressibility and kinking resistance of ringed grafts may shed light on a direction for the future development of dialysis graft design.

Entities:  

Mesh:

Year:  2010        PMID: 20378642      PMCID: PMC2879306          DOI: 10.2215/CJN.08181109

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

1.  Comparative study of use of Diastat versus standard wall PTFE grafts in upper arm hemodialysis access.

Authors:  P J Almonacid; E C Pallares; A Q Rodriguez; J S Valdes; J A Rueda Orgaz; J R Polo
Journal:  Ann Vasc Surg       Date:  2000-11       Impact factor: 1.466

2.  Surgical thrombectomy for thrombosed dialysis grafts: comparison of adjunctive treatments.

Authors:  Yun-Hen Liu; Yen-Ni Hung; Hung-Chang Hsieh; Po-Jen Ko
Journal:  World J Surg       Date:  2007-12-08       Impact factor: 3.352

Review 3.  Conduits for hemodialysis access.

Authors:  Eric C Scott; Marc H Glickman
Journal:  Semin Vasc Surg       Date:  2007-09       Impact factor: 1.000

Review 4.  Grafts and graft materials as vascular substitutes for haemodialysis access construction.

Authors:  L Berardinelli
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-02-20       Impact factor: 7.069

5.  A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.

Authors:  A G Stack; W E Bloembergen
Journal:  Am J Kidney Dis       Date:  2001-11       Impact factor: 8.860

6.  Hospital utilization among chronic dialysis patients.

Authors:  Pradeep Arora; Annamaria T Kausz; Gregorio T Obrador; Robin Ruthazer; Samina Khan; Constance S Jenuleson; Klemens B Meyer; Brian J G Pereira
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

7.  Femorofemoral bypass grafts: Factors influencing long-term patency rate and outcome.

Authors:  A Mingoli; P Sapienza; R J Feldhaus; L Di Marzo; C Burchi; A Cavallaro
Journal:  Surgery       Date:  2001-04       Impact factor: 3.982

8.  Effect of dipyridamole plus aspirin on hemodialysis graft patency.

Authors:  Bradley S Dixon; Gerald J Beck; Miguel A Vazquez; Arthur Greenberg; James A Delmez; Michael Allon; Laura M Dember; Jonathan Himmelfarb; Jennifer J Gassman; Tom Greene; Milena K Radeva; Ingemar J Davidson; T Alp Ikizler; Gregory L Braden; Andrew Z Fenves; James S Kaufman; James R Cotton; Kevin J Martin; James W McNeil; Asif Rahman; Jeffery H Lawson; James F Whiting; Bo Hu; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

Review 9.  Cardiovascular mortality in end-stage renal disease.

Authors:  Allan J Collins
Journal:  Am J Med Sci       Date:  2003-04       Impact factor: 2.378

10.  Effect of demographic characteristics and timing of vascular access maturation on patency in Chinese incident haemodialysis patients.

Authors:  Yee-Yung Ng; Shiao-Chi Wu; Yen-Ni Hung; Po-Jen Ko
Journal:  Nephrol Dial Transplant       Date:  2009-06-08       Impact factor: 5.992

View more
  6 in total

1.  Coaxially-structured fibres with tailored material properties for vascular graft implant.

Authors:  Richard Johnson; Yonghui Ding; Naveen Nagiah; Eric Monnet; Wei Tan
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2018-11-30       Impact factor: 7.328

Review 2.  Stent Graft Outcomes in Dialysis Circuits: A Review of Clinical Trials and Literature.

Authors:  Austin J Pourmoussa; Ashwin M Mahendra; Constantino S Peña; Alex Powell; Brian J Schiro; Raul Herrera; Barry T Katzen; Govindarajan Narayanan; Andrew S Niekamp; Ripal T Gandhi
Journal:  Semin Intervent Radiol       Date:  2022-02-18       Impact factor: 1.513

3.  Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis.

Authors:  Fu-An Chen; Chih-Chiang Chien; Yu-Wei Chen; Yu-Te Wu; Chih-Ching Lin
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

4.  Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.

Authors:  Ka-Wai Tam; Mei-Yi Wu; Fahad Javaid Siddiqui; Edwin Sy Chan; Yanan Zhu; Tazeen H Jafar
Journal:  Cochrane Database Syst Rev       Date:  2018-11-18

5.  Assessment of Novel Anti-thrombotic Fusion Proteins for Inhibition of Stenosis in a Porcine Model of Arteriovenous Graft.

Authors:  Christi M Terry; Ilya Zhuplatov; Yuxia He; Tze-Chein Wun; Seong-Eun Kim; Alfred K Cheung
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

6.  Vascular access cannulation in hemodialysis patients: technical approach.

Authors:  Manuel Carlos Martins Castro; Francisca Tokiko Yanagida Carlquist; Celina de Fátima Silva; Magdaleni Xagoraris; Jerônimo Ruiz Centeno; José Adilson Camargo de Souza
Journal:  J Bras Nefrol       Date:  2019-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.